CTO

Colombia 2022 45th Regional Sessions Starts This Week

October 6, 7 and 8, Bucaramanga, Colombia After 5 years, SOLACI is back in Colombia to hold our Regional Sessions together with CCHICV´s Colombian Congress of Hemodynamics.  The event will take place at Bucaramanga Country Club and will feature prestigious Colombian and Latin American guests, as well as a cutting-edge scientific program with the latest innovations in interventional cardiology.  There will be fascinating...

nefroproteccion

TEATE Trial: Urine Alkalinization as a Target to Prevent Contrast-Associated Kidney Injury

Acute kidney injury related to iodinated contrast significantly increases morbidity and mortality after angiography or angioplasty. According to registries, its prevalence can vary from 2% in low-risk population to up to 50% in high-risk subjects. Its risk factors include previous renal failure, diabetes, age, and the amount/type of contrast used. As a preventive measure, international...

La enfermedad vascular periférica se asocia a más eventos en el TAVI

Is Right Ventricle-Pulmonary Artery (RV-PA) Coupling Important in Low Risk TAVR?

TAVR has long been an effective strategy to treat aortic stenosis. However, ventricular damage starts further before symptom onset, also affecting the left ventricle, pulmonary vessels, the right ventricle, the tricuspid valve, and the right atrium.  It increases arterial afterload and uncouples the right ventricle and the pulmonary artery, defined by transthoracic echocardiogram as the relationship...

Simposio MINT - MIL

SOLACI and the Latin American Interventional Women Group (Grupo MIL) Support the I Mentoring, Leadership, and Professional Development Symposium Organized by SBHCI-MINT

SOLACI invites everyone to participate in the I Mentoring, Leadership, and Professional Development Symposium organized by SBHCI-MINT, on October 12th. The event is supported by SOLACI and, more precisely, by the Latin American Interventional Women Group (MIL), whose presence in the scientific program is marked by the participation of Dr. Carla Agatiello and Ana Paula...

struts ultrafinos

Should We Start Using Ultra-Thin Struts?

The benefits of DES are well known, as well as the benefits of more recent polymer-based DES versions (even those with no polymers). However, strut size is no small matter, and might even make the difference, seeing as thinner struts are associated to better deliverability, simpler crossing profile in bifurcations, better endothelization and healing. Besides,...

TCT 2022

TCT 2022 | FAME-3 Trial: post PCI FFR And IVUS in Patients with Three-Vessel Disease

We are well aware of the benefits of Fractional Flow Reserve (FFR) to assess coronary artery stenosis. FFR after PCI (post-PCI FFR) has been shown to have prognostic value; however, few studies have included patients with complex three-vessel disease. The impact of intravascular ultrasound (IVUS) or optical computer tomography (OCT) in this field has been...

TCT 2022

TCT 2022 | AMULET IDE: Events at 3 Years Using the AMULET Appendage Closure Device

The aim of this study was to assess the 3-year efficacy for the endpoints of the AMULET Occluder (Abbott) left atrial appendage closure device compared with the Watchman 2.5 device. The evaluated endpoints were analyzed according to a “per protocol” population, assessing a composite of stroke, systemic embolism, or cardiovascular death. The secondary endpoints were...

TCT 2022

TCT 2022 | FRANCE-TAVI Registry: Small Annuli

The presence of small annuli, defined in this registry as < 23 mm diameter or indexed diameter <12 mm/m2 by CT, continues to be one of the greatest challenges of both surgical and endovascular aortic valve treatments. The FRANCE-TAVI Registry looked at 1,195 patients presenting small annuli. 895 (74.9%) received balloon expandable valves (BEV) and...

SOLACI-SOCIME 2022 - Distal Left Main Coronary Artery

Complex PCI: Distal Left Main Coronary Artery – SOLACI-SOCIME 2022

✔️ Complex PCI: Distal Left Main Coronary Artery – SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session.  👨‍🏫 Contents: 00:13 – Welcoming words – Dr. Álvaro Contreras (MEX) 01:18 – LM-PCI: IVUS and FFR/IFR? – Dr. Hector García-García (USA) 17:06 – DK Crush or provisional stenting? – Dr. Carlos Uribe (COL) 32:22 – Optimal antiplatelet anti...

Top